Literature DB >> 6116610

Comparative study of the ventilatory effects of three beta 1-selective blocking agents in asthmatic patients.

A P Greefhorst, C L van Herwaarden.   

Abstract

A double blind, placebo-controlled study of the ventilatory effects of three new beta 1-selective adrenoceptor blockers was carried out in eight asthmatic patients. Measurements were performed before and 2, 3 and 4 h after ingestion of a single oral dose of placebo, atenolol 100 mg, metoprolol 100 mg or acebutolol 400 mg. At each time ventilatory indices and heart rate were assessed before, during and 15 min after an exercise test. The ventilatory indices were re-assessed after challenge with terbutaline 1.5 mg by inhalation. The three beta-blocking agents caused equal falls in exercise heart rate two hours after ingestion, indicating the equipotency of the cardiac effects. The three agents reduced significantly and to the same extent FEV1 and PEFR both before and after exercise. The respiratory indices clearly improved after stimulation with terbutaline. The response to terbutaline was less marked after acebutolol, which may indicate that it has a lower degree of beta 1-selectivity. The beta-blockers did not show any influence on bronchodilatation during exercise, or on exercise-induced bronchospasm.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116610     DOI: 10.1007/bf00542093

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease.

Authors:  L A Nordstrom; F MacDonald; F L Gobel
Journal:  Chest       Date:  1975-03       Impact factor: 9.410

2.  Direct evidence of two types of beta adrenoceptor binding site in lung tissue.

Authors:  D B Barnett; E L Rugg; S R Nahorski
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

Review 3.  Exercise-induced asthma: Observations on the initiating stimulus.

Authors:  E R McFadden; R H Ingram
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

4.  Effect of atenolol on ventilatory and cardiac function in asthma.

Authors:  J S Vilsvik; J Schaanning
Journal:  Br Med J       Date:  1976-08-21

5.  The time course of maximum ventilatory performance during and after moderately heavy exercise.

Authors:  N M Lefcoe
Journal:  Clin Sci       Date:  1969-02       Impact factor: 6.124

6.  Respiratory effects of acebutolol hydrochloride.

Authors:  W P Leary; A J Coleman; A C Asmal
Journal:  S Afr Med J       Date:  1973-07-21

7.  Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics.

Authors:  G Johnsson; N Svedmyr; G Thiringer
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

8.  Acebutolol metabolite plasma concentration during chronic oral therapy.

Authors:  R A Winkle; P J Meffin; W B Ricks; D C Harrison
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

9.  Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.

Authors:  C L van Herwaarden; R A Binkhorst; J F Fennis; A van't Laar
Journal:  Br Heart J       Date:  1979-01

10.  Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.

Authors:  W H Perks; S S Chatterjee; R S Croxson; J M Cruickshank
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

View more
  11 in total

1.  The effects of pafenolol and metoprolol on ventilatory function and haemodynamics during exercise by asthmatic patients.

Authors:  C G Löfdahl; G E Marlin; N Svedmyr
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  New drugs: beta blockers and sympathomimetics.

Authors:  J Feely; D Maclean
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-18

Review 3.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

4.  Absence of respiratory effects with ivabradine in patients with asthma.

Authors:  K Suresh Babu; Frantisek Gadzik; Stephen T Holgate
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

5.  Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.

Authors:  A P Greefhorst; C L van Herwaarden
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Ventilatory and haemodynamic effects of terbutaline infusion during beta 1-selective blockade with metoprolol and acebutolol in asthmatic patients.

Authors:  A P Greefhorst; C L van Herwaarden
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Comparative study of the respiratory effects of two beta 1-selective blocking agents atenolol and bevantolol in asthmatic patients.

Authors:  F Philip-Joet; A Saadjian; B Bruguerolle; A Arnaud
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.

Authors:  J W Lammers; M E Müller; H T Folgering; C L van Herwaarden
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

Review 9.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

Review 10.  Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.

Authors:  Jillian G Baker; Stephen J Hill; Roger J Summers
Journal:  Trends Pharmacol Sci       Date:  2011-03-21       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.